AHA 2020 | The More Operators “Listen” to FFR, the Lower the Risk

When operators decide to proceed with PCI despite a negative FFR (fairly frequent in the daily practice) outcomes at 5 years are far worse. This information comes from a large Canadian register presented at AHA 2020 Scientific Sessions, simultaneously published in JAMA.

AHA 2020 | El riesgo aumenta cuando los operadores no “escuchan” al FFR

PCI to a non-ischemic lesion results in increased events risk at long term, just as treating an ischemic lesion with medical treatment would. 

Both the American and the European guidelines have emphasized the idea of using FFR to guide revascularization in intermediate lesions. Even though these recommendations have clearly been established, they are hardly followed in the daily practice. 

In the present study, researchers speculated with the fact that PCI to severe lesions with negative FFR would not present a major problem. Eventually, it would only increase healthcare costs. However, they observed increased events rate. 

The registry included 9106 patients (mean age 65) undergoing FFR in one vessel only between 2013 and 2018. It excluded STEMI or left main patients. 


Read also: AHA 2020 | AFFIRM-AHF: Ferric Carboxymaltose and Fewer Hospitalizations for Cardiac Failure.


Globally, 30% of patients showed ischemic lesions (FFR ≤ 0.8) and 70% non-ischemic lesions.

In the ischemic lesion group, 75% of patients received PCI and 25% medical treatment, despite a positive FFR. In this group, PCI reduced the primary end point of death, MI, unstable angina or urgent revascularization (31.5% vs 39.1%; HR 0.77; CI 95% 0.63-0.94).

On the other end, 87.4% of patients with non-ischemic lesions received medical treatment and 12.6% received PCI, despite a negative FFR. This unnecessary intervention was associated with a significant increase in events at 5 years (33.3% vs 24.4%; HR 1.37; CI 95% 1.14-1.65).


Read also: AHA 2020 | Statins: Confirmed Benefits for the Elderly.


What is interesting about this study is that FFR was measured, but then it was decided against its result. More often than not, interventionists in the daily practice often decide not to measure FFR because they rely on angiographies.  

Taking the time to measure FFR and then ignoring its results strikes as odd, but there must be a reason behind this decision. 

FFR is not binary and there are multiple factors an operator must take into account when deciding for or against revascularization. 

FFR

Original Title: Association Between Adherence to Fractional Flow Reserve Treatment Thresholds and Major Adverse Cardiac Events in Patients With Coronary Artery Disease.

Reference: Maneesh Sud et al. JAMA. Published online November 13, 2020. doi:10.1001/jama.2020.22708 y presentado en el congreso AHA 2020.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

AHA 2024 | SUMMIT

It has been previously shown that the pharmacological treatment of obesity (semaglutide) can reduce cardiovascular events in patients with cardiac failure (CF) and preserved...

AHA 2024 – BPROAD

Hypertension (elevated blood pressure, BP) is the most common comorbidity among diabetic patients and has been associated with higher cardiovascular risk, though as a...

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

Evolution of Small Balloon-Expandable Valves

Small aortic rings (20 mm) have posed a significant challenge for both surgery and transcatheter aortic valve implantation (TAVI) due to their association with an...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Long Term Results of the International Chimney Registry

The International Chimney Registry was an observational study aimed at assessing the use of chimney stenting during TAVR either to predict or treat coronary...

CANNULATE TAVR extended study: Impact of Commissural and Coronary Alignment in Coronary Cannulation Following TAVR with Evolut Fx

The new valve Evolut FX has shown better commissural alignment vs. its predecessor Evolut Pro+. Prior studies have already shown commissure alignment facilitates post...

TRISCEND II: Transcatheter Replacement vs. Medical Treatment for Tricuspid Regurgitation

The EVOQUE device is designed with an intra-annular sealing system that provides excellent anatomical compatibility and an adaptable shape. It is currently available in...